<International Circulation>:What is the latest progress regarding the treatment methods for pulmonary hypertension? Which method do you have the most hope for in the near future?

   《国际循环》：您在演讲中深入阐述了改进的诊断和肺动脉高压分型，能否介绍一下主要内容？在肺动脉高压治疗的最新进展方面，您认为哪种治疗前景最好？是改善的药物治疗还是干细胞治疗？

    Prof.Galie:We should improve the performance of our activities at different levels. First of all， there must be implementation of the guidelines. Secondly， we need an appropriate organization for treatment because this is a rare disease and for a rare disease it is important to have few well-organized and experienced centers and this requires the collaboration of health care providers. Of course， from the scientific point of view， it is also important to continue research because even if we have several molecules that have been approved， we need to continue research and explore new areas like regenerative medicine.

    Galie教授:我们应当在多个层面上努力。首先，我们要遵循指南；其次，建立正规的治疗中心，肺动脉高压是一种严重的疾病，因此建立一些组织有序、经验丰富的治疗中心很重要，这需要医务人员之间的合作；最后，当然从学术角度来讲，继续深入研究仍很重要，因为尽管被批准用于治疗的药物已达到八种，我们还是要继续研究，比如探索再生治疗这些新领域。

bookbook